Brief: Prostatype Genomics Q1 EBITDA Loss At SEK 7.3 Mln
31/05/2023 07:24
May 31 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* Q1 NET SALES AMOUNTED TO SEK 392,000
* Q1 EBITDA LOSS AMOUNTED TO SEK 7.3 MILLION
Source text for Eikon: ID:nWkrbx2pQX
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants